NCT06709144Active, not recruitingPhase 3
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC): a Prospective, Multicenter Randomized Control Clinical Trial
Source: ClinicalTrials.gov · Last updated 29 Nov 2024
Brief summary (registry, in English)
The study was conducted on patients with advanced right-sided colon cancer, and the clinical pathological and prognostic data of the patients were compared between the two groups of patients who were randomly divided into those undergoing SMV and SMA left resection, with the aim of resolving the controversy over the left resection boundary of CME/D3 lymph node dissection through this study, and to clarify whether SMA left resection is superior to SMV left resection.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 896 (estimated)
- First submitted
- 18 Nov 2024
- Start date
- 1 Jul 2024
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Haixing Ju, MD
- Diseases
- Colorectal cancer
- NCT number
- NCT06709144
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 896
- From 1 Jul 2024 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cannot undergo curative resection
- Tumor invades surrounding organs, requiring joint organ resection
- Patients who have received neoadjuvant therapy before surgery
- Patients who are not suitable or unable to tolerate surgery
Other illness
- Simultaneous multiple primary colorectal cancer or other diseases requiring segmental resection
- Emergency surgery is required for complications such as intestinal obstruction, perforation, and bleeding
Other
- T1-2N0M0
- Distant metastasis
- Pregnant or lactating women
Who the study is looking for
- right side colon cancer(The primary lesion is located in the ileocecal region, ascending colon, hepatic flexure of colon, or proximal transverse colon)
- T3-4 and/or N1-2M0
- Colonoscopy and pathological biopsy confirmed colon adenocarcinoma
Age in the registry: 18 years to 78 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Cancer Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.